<?xml version="1.0" encoding="UTF-8"?>



<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Mark Borigini, MD's SharePosts</title>
    <description>Osteoporosis Expert Mark Borigini, MD shares Osteoporosis management news and commentary at OsteoporosisConnection.com. 

 The HealthCentral Network, Inc. (www.HealthCentral.com) is one of the top health destinations on the Web, with more than 35 condition-specific, wellness and general health Web properties.</description>
    <link>http://www.healthcentral.com/osteoporosis/c/7361</link>
    <atom:link>
      <href>http://www.healthcentral.com/osteoporosis/c/7361/rss</href>
      <rel>self</rel>
      <type>application/xml</type>
    </atom:link>
    <language>en-us</language>
    <ttl>15</ttl>
    <image>
      <title>Mark Borigini, MD's SharePosts</title>
      <width>120</width>
      <height>19</height>
      <url>http://www.healthcentral.com/images/hc_logo_sm.gif</url>
      <link>http://www.healthcentral.com/osteoporosis/c/7361</link>
    </image>
    <item>
      <guid>http://www.healthcentral.com/osteoporosis/c/7361/10755/afflictions</guid>
      <pubDate>Tue, 26 Jun 2007 14:23:01 -0000</pubDate>
      <dc:creator>Mark Borigini, MD</dc:creator>
      <title>Osteoporosis and Osteonecrosis and other Jaw-Dropping Afflictions </title>
      <description>
Recently, an article appeared in the Journal of the National Cancer Institute, suggesting that patients treated with intravenous bisphosphonates are at greater risk of jaw or facial bone deterioration or infection.&amp;nbsp; But the authors were not sure whether the bisphosphonates caused the bone problem, or whether these patients whose immune systems are suppressed were naturally more prone to such complications.&amp;nbsp; In fact, there are those...</description>
      <link>http://www.healthcentral.com/osteoporosis/c/7361/10755/afflictions</link>
    </item>
  </channel>
</rss>
